Xin Hongqi, Li Yi, Liu Zhongwu, Wang Xinli, Shang Xia, Cui Yisheng, Zhang Zheng Gang, Chopp Michael
Department of Neurology, Henry Ford Hospital, Detroit, Michigan, USA.
Stem Cells. 2013 Dec;31(12):2737-46. doi: 10.1002/stem.1409.
To test, in vivo, the hypothesis that exosomes from multipotent mesenchymal stromal cells (MSCs) mediate microRNA 133b (miR-133b) transfer which promotes neurological recovery from stroke, we used knockin and knockdown technologies to upregulate or downregulate the miR-133b level in MSCs (miR-133b(+) MSCs or miR-133b(-) MSCs) and their corresponding exosomes, respectively. Rats were subjected to middle cerebral artery occlusion (MCAo) and were treated with naïve MSCs, miR-133b(+) MSCs, or miR-133b(-) MSC at 1 day after MCAo. Compared with controls, rats receiving naïve MSC treatment significantly improved functional recovery and exhibited increased axonal plasticity and neurite remodeling in the ischemic boundary zone (IBZ) at day 14 after MCAo. The outcomes were significantly enhanced with miR-133b(+) MSC treatment, and were significantly decreased with miR-133b(-) MSC treatment, compared to naïve MSC treatment. The miR-133b level in exosomes collected from the cerebral spinal fluid was significantly increased after miR-133b(+) MSC treatment, and was significantly decreased after miR-133b(-) MSC treatment at day 14 after MCAo, compared to naïve MSC treatment. Tagging exosomes with green fluorescent protein demonstrated that exosomes-enriched extracellular particles were released from MSCs and transferred to adjacent astrocytes and neurons. The expression of selective targets for miR-133b, connective tissue growth factor and ras homolog gene family member A, was significantly decreased in the IBZ after miR-133b(+) MSC treatment, while their expression remained at similar elevated levels after miR-133b(-) MSC treatment, compared to naïve MSC treatment. Collectively, our data suggest that exosomes from MSCs mediate the miR-133b transfer to astrocytes and neurons, which regulate gene expression, subsequently benefit neurite remodeling and functional recovery after stroke.
为了在体内验证多能间充质基质细胞(MSC)分泌的外泌体介导微小RNA 133b(miR-133b)转移从而促进中风后神经功能恢复这一假说,我们运用敲入和敲低技术分别上调或下调MSC(miR-133b(+) MSC或miR-133b(-) MSC)及其相应外泌体中的miR-133b水平。大鼠接受大脑中动脉闭塞(MCAo)手术,并在MCAo术后第1天用未处理的MSC、miR-133b(+) MSC或miR-133b(-) MSC进行治疗。与对照组相比,接受未处理的MSC治疗的大鼠在MCAo术后第14天功能恢复显著改善,缺血边界区(IBZ)的轴突可塑性和神经突重塑增加。与未处理的MSC治疗相比,miR-133b(+) MSC治疗的效果显著增强,而miR-133b(-) MSC治疗的效果显著降低。与未处理的MSC治疗相比,在MCAo术后第14天,miR-133b(+) MSC治疗后从脑脊液中收集的外泌体中的miR-133b水平显著升高,而miR-133b(-) MSC治疗后则显著降低。用绿色荧光蛋白标记外泌体表明,富含外泌体的细胞外颗粒从MSC释放并转移到相邻的星形胶质细胞和神经元。与未处理的MSC治疗相比,miR-133b(+) MSC治疗后IBZ中miR-133b的选择性靶标结缔组织生长因子和ras同源基因家族成员A的表达显著降低,而在miR-133b(-) MSC治疗后它们的表达仍维持在相似的升高水平。总体而言,我们的数据表明,MSC分泌的外泌体介导miR-133b转移至星形胶质细胞和神经元,调节基因表达,随后有益于中风后的神经突重塑和功能恢复。